Fresenius Kabi Taiwan Ltd.
Clinical trials sponsored by Fresenius Kabi Taiwan Ltd., explained in plain language.
A subsidiary of Fresenius Kabi, providing infusion, transfusion, and clinical nutrition products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New drink flavors aim to help kidney patients stay nourished
Disease control CompletedThis study tested two flavors of a high-energy, low-protein drink called Renalive® LP in 74 adults with chronic kidney disease stages 3b-5. Participants drank the formula as a meal replacement or supplement for 4 weeks. The goal was to see if the drink was suitable and helped mai…
Phase: NA • Sponsor: Fresenius Kabi Taiwan Ltd. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New flavored drink helps cancer patients keep weight on during treatment
Disease control CompletedThis study tested three flavors of Supportan® drink (Tropical Fruits, Cappuccino, and Pineapple-Coconut) in 123 cancer patients undergoing chemotherapy, radiotherapy, immunotherapy, or targeted therapy. Patients drank two bottles daily for four weeks alongside their normal diet. …
Phase: NA • Sponsor: Fresenius Kabi Taiwan Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC